发展战略 |
|
|
|
|
我国医药制造业的区域分工现状分析 |
桑晓冬,魏巍,张小奕,李苏宁,濮润,敖翼,范玲*() |
中国生物技术发展中心 北京 100039 |
|
Analysis of the Current Situation of Regional Division of Labor in China’s Pharmaceutical Manufacturing Industry |
SANG Xiao-dong,WEI Wei,ZHANG Xiao-yi,LI Su-ning,PUN Run,AO Yi,FAN Ling*() |
China National Center for Biotechnology Development, Beijing 100039, China |
引用本文:
桑晓冬, 魏巍, 张小奕, 李苏宁, 濮润, 敖翼, 范玲. 我国医药制造业的区域分工现状分析[J]. 中国生物工程杂志, 2023, 43(9): 113-119.
SANG Xiao-dong, WEI Wei, ZHANG Xiao-yi, LI Su-ning, PUN Run, AO Yi, FAN Ling. Analysis of the Current Situation of Regional Division of Labor in China’s Pharmaceutical Manufacturing Industry. China Biotechnology, 2023, 43(9): 113-119.
链接本文:
https://manu60.magtech.com.cn/biotech/CN/10.13523/j.cb.2304041
或
https://manu60.magtech.com.cn/biotech/CN/Y2023/V43/I9/113
|
[1] |
唐家龙. 新阶段我国生物医药产业的发展态势与对策建议. 科技与金融, 2021(5): 5-10.
|
|
Tang J L. Development trend and countermeasures of China’s biomedical industry in the new stage. STF Monthly, 2021(5): 5-10.
|
[2] |
陈凯先. 生物医药科技创新前沿、我国发展态势和新阶段的若干思考. 中国食品药品监管, 2021(8): 4-17.
|
|
Chen K X. Advances in biopharmaceutical science and technology, innovative biologics in China and discussion of drug development at the new development stage. China Food Drug Administration, 2021(8): 4-17.
|
[3] |
张晓燕, 倪春霞. 中国医药制造业的市场结构分析. 医院管理论坛, 2016, 33(8):6-8.
|
|
Zhang X Y, Ni C X. Analysis on market structure of China’s pharmaceutical manufacturing industry. Hospital Management Forum, 2016, 33(8):6-8.
|
[4] |
褚淑贞, 沈念伍. 基于区位商的医药制造业区域结构分析. 上海医药, 2011, 32(9): 457-461.
|
|
Chu S Z, Shen N W. The region structure analysis of the pharmaceutical manufacturing based on the location quotient. Shanghai Medical&Pharmaceutical Journal, 2011, 32(9):457-461.
|
[5] |
那威. 京津冀工业主导产业现状分析. 现代经济信息, 2013(14): 429-429.
|
|
Na W. Analysis on the present situation of leading industries in Beijing, Tianjin and Hebei. Modern Economic Information, 2013(14): 429-429.
|
[6] |
濮润, 董丽娟, 唐尚锋, 等. 我国区域生物医药产业分工研究. 医药导报, 2019, 38(10):1376-1378.
|
|
Pu R, Dong L J, Tang S F, et al. Research on division of labor of regional biomedical industry in China. Herald of Medicine, 2019, 38(10):1376-1378.
|
[7] |
龙晖, 齐铮, 吴昊. 重庆市生物医药产业发展现状与对策建议: 以人才链为牵引加快生物医药高新园区社区建设. 中国生物工程杂志, 2023, 43(5): 94-105.
|
|
Long H, Qi Z, Wu H. Development status and countermeasures of Chongqing biomedicine industry: accelerating the construction of biomedical high-tech parks with the “talent chain” as the driving force. China Biotechnology, 2023, 43(5): 94-105.
|
[8] |
赵奚. 吉林省生物产业发展困境探析与突破. 科技和产业, 2020, 20(4):109-111.
|
|
Zhao X. Analysis and breakthrough to the development dilemma of Jilin Province’s biological industry. Science Technology and Industry, 2020, 20(4):109-111.
|
[9] |
张琪绮, 卜琳麟, 苏红. 基于熵值法的长三角地区生物医药产业集群竞争力分析. 中国医药工业杂志, 2022, 53(5):754-759.
|
|
Zhang Q Q, Bu L L, Su H. Competitiveness analysis of pharmaceutical industry cluster in the Yangtze River Delta based on entropy method. Chinese Journal of Pharmaceuticals, 2022, 53(5):754-759.
|
[10] |
徐凯, 孙利华. 我国生物医药产业园区发展现状及存在问题. 中国新药杂志, 2019, 28(20): 2440-2446.
|
|
Xu K, Sun L H. Development status and existing problems of biopharmaceutical industrial parks in China. Chinese Journal of New Drugs, 2019, 28(20):2440-2446.
|
|
Viewed |
|
|
|
Full text
|
|
|
|
|
Abstract
|
|
|
|
|
Cited |
|
|
|
|
|
Shared |
|
|
|
|
|
Discussed |
|
|
|
|